share_log

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025

凱西·伍德的ARK再次減持Palantir,彼得·蒂爾共同創辦的公司的股票在2025年下跌近15%
Benzinga ·  01/14 07:27

On Monday, Cathie Wood-led Ark Invest made significant trades in five major companies: Palantir Technologies Inc. (NASDAQ:PLTR), Tempus AI Inc. (NASDAQ:TEM), CareDx Inc. (NASDAQ:CDNA), Veracyte Inc. (NASDAQ:VCYT), Adaptive Biotechnologies Corp. (NASDAQ:ADPT).

在週一,由Cathie Wood領導的ARK投資在五家主要公司中進行了重大交易:Palantir Technologies Inc. (納斯達克:PLTR)、Tempus AI Inc. (納斯達克:TEM)、CareDx Inc. (納斯達克:CDNA)、Veracyte Inc. (納斯達克:VCYT)、Adaptive Biotechnologies CORP. (納斯達克:ADPT)。

The PLTR Trade

PLTR交易

Ark Invest's Ark Innovation ETF (NYSE:ARKK) fund sold 140,518 shares of Palantir. This move is significant, considering Ark Invest's recent trend of offloading Palantir shares.

ARK投資的ARK Innovation ETF (紐交所:ARKK) 基金出售了140,518股Palantir。這一舉動意義重大,因爲ARK投資最近有減持Palantir股票的趨勢。

The total value of this trade, based on the latest closing price of $64.98, is approximately $9.1 million.

根據最新的收盤價$64.98,這筆交易的總價值約爲910萬。

This sale follows Ark's disposal of shares worth roughly $15 million the previous week.

這筆交易是繼上週ARK處置了價值約1500萬的股票後進行的。

Palantir stock price has fallen more than 14% over the past month. In just the first two weeks of 2025, the stock has declined nearly 15%.

Palantir的股價在過去一個月中下跌了超過14%。在2025年的前兩週,股價幾乎下降了15%。

The TEM Trade

TEm交易

Ark Invest's ARK Genomic Revolution ETF (BATS:ARKG) and ARKK funds made substantial purchases of Tempus AI Inc. shares. The ARKG fund bought 98,691 shares, while the ARKK fund purchased a whopping 280,192 shares.

ARK投資的ARK生物基因科技革新主動型ETF (BATS:ARKG) 和ARKk基金大規模購買Tempus AI Inc.的股票。ARKG基金購買了98,691股,而ARKk基金則購買了高達280,192股。

Given the latest closing price of $32.34, the total value of these trades amounts to approximately $12.2 million.

根據最新的收盤價32.34美元,這些交易的總價值約爲1220萬。

This move comes amid TEM's 13.81% drop on Monday.

此次交易發生在TEM週一下跌13.81%之際。

Other Key Trades:

其他關鍵交易:

Company ETF Transaction No. Of Shares Closing price Approx. Value
Veracyte Inc. (NASDAQ:VCYT) ARK Genomic Revolution Sale 37,358 $42.78 $1.6 million
Adaptive Biotechnologies Corp. (NASDAQ:ADPT) ARK Genomic Revolution Sale 76,522 $6.46 $494,332
CareDx Inc. (NASDAQ:CDNA) ARK Genomic Revolution Sale 65,550 $25.07 $1.6 million
公司 可交易ETF Transaction 股份數量 收盤價 大約價值
Veracyte公司(納斯達克:VCYT) ARK生物基因科技革新 銷售 37,358 $42.78 $160萬
Adaptive Biotechnologies CORP(納斯達克:ADPT) ARK生物基因科技革新 銷售 76,522 $6.46 $494,332
CareDx Inc. (納斯達克:CDNA) ARK生物基因科技革新 銷售 65,550 $25.07 $160萬

Closing price as of Jan. 13, 2025

截至2025年1月13日的收盤價

  • Mark Zuckerberg Critiques 'Culturally Neutered' Companies, Advocates For 'Masculine Energy' As Meta Cuts DEI Programs Post-Joe Rogan Appearance
  • 馬克·扎克伯格批評 "文化中立 "的公司,倡導 "男性能源 ",同時Meta在喬·羅根出現在後削減DEI項目。

Image via Benzinga YouTube and Unsplash

圖片來源:Benzinga YouTube和Unsplash

This story was generated using Benzinga Neuro and edited by Rounak Jain

這個故事是使用Benzinga Neuro生成並由 Rounak Jain

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論

    聲明

    本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。